Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;5(5):401-409.
doi: 10.1002/ame2.12278.

Characteristics of animal models for COVID-19

Affiliations
Review

Characteristics of animal models for COVID-19

Feifei Qi et al. Animal Model Exp Med. 2022 Oct.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), the most consequential pandemic of this century, threatening human health and public safety. SARS-CoV-2 has been continuously evolving through mutation of its genome and variants of concern have emerged. The World Health Organization R&D Blueprint plan convened a range of expert groups to develop animal models for COVID-19, a core requirement for the prevention and control of SARS-CoV-2 pandemic. The animal model construction techniques developed during the SARS-CoV and MERS-CoV pandemics were rapidly deployed and applied in the establishment of COVID-19 animal models. To date, a large number of animal models for COVID-19, including mice, hamsters, minks and nonhuman primates, have been established. Infectious diseases produce unique manifestations according to the characteristics of the pathogen and modes of infection. Here we classified animal model resources around the infection route of SARS-CoV-2, and summarized the characteristics of the animal models constructed via transnasal, localized, and simulated transmission routes of infection.

Keywords: SARS-CoV-2; animal model; characteristics; establishment.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflict of interest. Chuan Qin is an Editorial Board member of AMEM and a co‐author of this article. To minimize bias, she was excluded from all editorial decision‐making related to the acceptance of this article for publication.

Figures

FIGURE 1
FIGURE 1
Mouse models for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Similar articles

Cited by

References

    1. Sancho Ferrando E, Hanslin K, Hultström M, et al. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID‐19 patients: a prospective observational study. Cytokine. 2022;149:155727. - PMC - PubMed
    1. Zeng J, Liu Y, Yuan J, et al. First case of COVID‐19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):773‐777. - PMC - PubMed
    1. Pe F, Mc A, Sd C, et al. Association Between Comorbidities and Death From COVID‐19 in Different Age Groups. Cold Spring Harbor Laboratory Press; 2021.
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China JAMA. 2020;323(11):1061‐1069. - PMC - PubMed
    1. Jiang N, Liu Y‐N, Bao J, et al. Clinical features and risk factors associated with severe COVID‐19 patients in China. Chin Med J (Engl). 2021;134(8):944‐953. - PMC - PubMed

Publication types